Search - tctmd.com

June 14, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

May 02, 2024

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

January 06, 2023

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

August 15, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

December 23, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

April 01, 2021

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Todd Neale

February 08, 2021

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

July 20, 2020

News Features

Cardiology After COVID-19: Physicians Predict Lasting Change

Yael L. Maxwell

May 20, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

May 12, 2020

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

April 29, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

April 23, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

April 07, 2020

News Features

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

April 30, 2019

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

October 22, 2018

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

May 02, 2018

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Todd Neale

September 15, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

September 13, 2017

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts